Dr. Reddy's Laboratories Ltd Common Stock (RDY)

Total Liabilities

₹188.57B

Quarterly · Period ending: · INR

RDY logo

RDY Total Liabilities

Latest reported₹188.57B INR
RDY Quarterly Total Liabilities · INR (₹3.83B → ₹188.57B)
High-resolution chart · PNG

RDY total liabilities history

Quarterly · INR. Dates are reporting period ends; fiscal years can differ from calendar years.

Dr. Reddy's Laboratories Ltd Common Stock Total Liabilities — Quarterly (INR)
Period endingTotal Liabilities (INR)
188,570,000,000
194,951,533,000
187,143,000,000
179,923,000,000
165,782,000,000
155,823,000,000
159,494,000,000
156,672,000,000
120,670,000,000
106,968,000,000
1,261,714,560
93,936,000,000
89,781,000,000
90,863,000,000
1,076,115,073
1,041,766,414
1,210,370,698
1,350,049,488
1,244,127,144
1,274,083,055
1,346,697,161
1,264,180,814
1,135,265,336
1,193,277,310
1,185,305,365
1,021,172,816
969,848,616
80,045,000,000
80,882,000,000
85,230,000,000
90,967,000,000
102,788,000,000
100,450,000,000
99,144,000,000
102,271,000,000
100,178,000,000
94,964,000,000
95,777,000,000
106,148,000,000
105,151,000,000
81,413,000,000
79,314,000,000
79,201,000,000
80,988,000,000
82,315,000,000
83,460,000,000
79,292,000,000
77,314,000,000
76,814,000,000
79,422,000,000
82,951,000,000
83,060,000,000
75,885,000,000
692,645,000,000
70,022,000,000
67,345,000,000
66,970,000,000
62,033,000,000
70,504,000,000
59,722,000,000
49,049,000,000
49,015,000,000
35,870,000,000
38,124,000,000
36,899,000,000
37,415,000,000
32,084,000,000
37,029,000,000
31,397,000,000
41,747,000,000
44,491,000,000
45,874,559,000
41,700,631,000
38,378,440,000
35,212,317,238
35,566,437,270
35,171,439,800
44,435,474,692
48,538,844,974
56,367,352,613
53,538,393,879
46,616,524,224
10,339,771,948
9,839,259,385
9,605,912,851
8,335,196,073
6,315,217,265
6,578,073,447
7,881,103,192
5,592,061,003
4,825,433,741
4,962,334,053
4,603,349,044
4,247,583,392
4,065,851,259
3,918,454,208
4,175,768,055
3,505,713,461
3,540,385,462
3,565,528,003
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.